Seven-year lack of NAFDAC at ports activated drug cabals in circulation– DG

The lack of the National Agency for Food and Drug Administration and Control (NAFDAC) from Nigeria’s ports for 7 years produced an environment in which illegal networks emerged within the pharmaceutical circulation worth chain, the firm’s Director-General has actually revealed.

The Director General of NAFDAC, Prof. Mojisola Adeyeye, who spoke in an interview on the sidelines of the 4th Thematic General Assembly of the African Pharmaceutical Distribution Association (APDA) and the Pharmaceutical Wholesalers and Distributors Association of Nigeria (PWDAN) Conference 2026 kept in Lagos on Thursday, stated the company was eliminated from the ports in between 2011 and May 16, 2018.

According to the DG, the extended lack of the regulative company from the points of entry weakened its capability to work out reliable oversight over the importation and exportation of managed pharmaceutical items.

READ: Customs obstructs 3 live pangolins hidden in sacks in Ogun

“NAFDAC was not present for 7 years at our port. Throughout that duration, cabals were formed,” the DG stated.

The disclosure can be found in action to claims that fake and falsified medication distributes might be running with the support of prominent people in society.

While Prof Adeyeye stated she might not develop who may be backing such networks, she worried that NAFDAC would continue to release its regulative required to secure public health.

“I do not understand who is backing them, however we will do what we require to do to safeguard our individuals,” the DG stated.

The firm’s position comes amidst restored focus on protecting Nigeria’s pharmaceutical supply chain versus falsified, substandard and illegally dispersed medications.

The NAFDAC DG stated the company’s regulative technique was based upon sanitising the pharmaceutical supply chain from the source, arguing that the quality and security of medications reaching clients depended upon controls at every phase of the circulation procedure.

“Supply chain is sanitised and it begins with the source. If the source is excellent, the transport is excellent, the storage conditions are excellent, then we have guarantee that the client will get what he’s expected to utilize,” the DG stated.

She recognized transport, storage and circulation controls as important links in making sure pharmaceutical item stability, while likewise highlighting innovation as a significantly essential tool for regulative security.

“We are going to utilize innovation. We are currently utilizing innovation to keep track of where medications go,” she stated.

The NAFDAC chief likewise required more powerful partnership in between the regulator and pharmaceutical market stakeholders, consisting of PWDAN and the Pharmaceutical Society of Nigeria (PSN), worrying that weak points in the supply chain might eventually expose clients to risky medications.

“PWDAN, NAFDAC, PSN, everyone, we have actually got to consider our individuals since it’s you and I and all people that usage medications. And if the supply chain is not sanitised, we’re tricking ourselves,” she stated.

The NAFDAC DG even more associated the decrease in the frequency of falsified medications to increased regulative awareness, adherence to worldwide requirements and management concentrated on public health.

She declined the concept of a different African requirement for pharmaceutical policy, worrying the value of compliance with globally acknowledged requirements.

“There is no African requirement. It is worldwide requirement,” she stated.

According to her, efficient policy needs considerable funds, including that funds contributed by regulated companies need to be released to enhance regulative activities and guarantee that non-compliant medications are eliminated from the marketplace.

“It costs a great deal of cash to manage,” the DG stated, including that NAFDAC was working constantly to guarantee that items that stop working to fulfill necessary quality requirements were secured of blood circulation.

The position of NAFDAC was echoed by the Chairman of PWDAN, Pharm. Oghenochuko Omaruaye, who stated the pharmaceutical market required a circulation architecture that showed up, traceable and liable.

Speaking at the conference themed “Advancing Pharmaceutical Distribution in Africa: Building Secure Supply Chains Against Falsified Medicines,” Omaruaye stated falsified medications, low quality items, illegal circulation channels and significantly advanced criminal networks stayed significant hazards to Africa’s health care systems.

He stated the effects of falsified medications extended beyond treatment failure, keeping in mind that they might wear down public self-confidence in health care organizations, boost health care expenses and intensify illness concerns.

“As suppliers, we inhabit a distinct position within the health care worth chain. We act as the bridge in between producers and clients. We are custodians of item stability. We are stewards of quality control. We are partners in public health,” he stated.

Omaruaye required higher release of innovation and data-driven tracking systems to enhance pharmaceutical traceability, stating every motion of a medication must eventually can being tracked, confirmed and verified.

He stated the future of pharmaceutical circulation depended upon safe supply chains in which falsified medications would end up being progressively challenging to make, present into genuine channels, disperse, and offer.